Ordinary Index Rebalancing in the Solactive Transatlantic Healthcare Equity Index | October 2021

In the ordinary rebalance the following composition will be implemented effective open 08.10.2021:

ABBOTT LABORATORIES
ABBVIE INC
AGILENT TECHNOLOGIES INC
AMGEN INC
ANTHEM INC
BAXTER INTL.
BECTON DICKINSON AND CO
BIO-RAD LABORATORIES INC
BOSTON SCIENTIFIC CORP
BRISTOL-MYERS SQUIBB CO
CHEMED CORP
COLOPLAST AS CLASS B
COOPER COMPANIES INC
DANAHER CORP
EDWARDS LIFESCIENCES CORP
ESSILORLUXOTTICA
FRESENIUS MEDICAL CARE AG & CO KGAA
FRESENIUS SE & CO KGAA
GILEAD SCIENCES INC
HIKMA PHARMACEUTICALS PLC
HUMANA INC
IQVIA HOLDINGS INC
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS NV
LABORATORY CRP OF AMER HLDGS
LONZA GROUP AG
MAGELLAN HEALTH INC
MEDTRONIC PLC
MERCK & CO. INC.
METTLER-TOLEDO INTL
NEOGEN CORP
NOVARTIS AG
NOVO NORDISK A/S
NOVOZYMES AS CLASS B
ORION OYJ CLASS B
PFIZER INC
QIAGEN NV
QUEST DIAGNOSTICS INC
RECORDATI SPA
REGENERON PHARMACEUTICALS
ROCHE HOLDING AG
SANOFI SA
SIEMENS HEALTHINEERS AG
STERIS PLC
STRYKER CORP
UCB SA
UNITEDHEALTH GROUP INC
WATERS CORP
WEST PHARMACEUTICAL SERVICES INC
ZOETIS INC